...
首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway
【24h】

Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway

机译:地塞米松通过TGF-β,Smad3和JAK-STAT途径减轻博来霉素诱导的小鼠肺纤维化

获取原文
           

摘要

In order to find the possible mechanism of Dexamethasone (Dex) during curing fibrosis, the bleomycin (BLM)-induced mice model was used. After fibrosis were induced by BLM, histopathological evaluation and RT-PCR were employed to detect the expression of TGF-β1, Smad3 and STAT1. It was found that BLM promoted the development of inflammation, leading to severe pulmonary fibrosis with the increasing of TGF-β1, Smad3 and STAT1. After Dex treatment, the expression of TGF-β1, Smad3 and STAT1 showed a little higher with alleviation of the fibrosis. Thus it is concluded that there is a possible pathway of mouse pulmonary fibrosis model through TGF-β, Smad3 and JAK-STAT pathway.
机译:为了找到地塞米松(Dex)在治疗纤维化过程中的可能机制,使用了博来霉素(BLM)诱导的小鼠模型。 BLM诱导纤维化后,采用组织病理学评价和RT-PCR检测TGF-β1,Smad3和STAT1的表达。发现BLM促进了炎症的发展,随着TGF-β1,Smad3和STAT1的增加导致严重的肺纤维化。经过Dex处理后,TGF-β 1,Smad3和STAT1的表达随纤维化的减轻而升高。因此得出结论,通过TGF-β,Smad3和JAK-STAT途径存在小鼠肺纤维化模型的可能途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号